SM
FMTX

Stephen Mandel’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Stephen Mandel’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-800,000
Closed -$18.6M – 44
2021
Q3 		$18.6M Hold
800,000
– – 0.06% 38
2021
Q2 		$19.9M Hold
800,000
– – 0.06% 34
2021
Q1 		$22.4M Hold
800,000
– – 0.08% 37
2020
Q4 		$27.9M Buy
+800,000
New +$34.8M 0.1% 40

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Stephen Mandel's FMTX Position: Q4 2021 in Review

Stephen Mandel sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2021, closing a stake of 800,000 shares — an estimated $18.6M sold.

Stephen Mandel first reported a position in FMTX in Q4 2020 and held it in 4 quarters. The position peaked at $27.9M in Q4 2020. 93 funds tracked by Wall St. Rank hold FMTX as of Q4 2021.

  • Stephen Mandel reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Stephen Mandel sold 800,000 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2021, an estimated $18.6M.
  • Stephen Mandel first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • Stephen Mandel's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $27.9M in Q4 2020.
  • 93 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2021.

Based on Lone Pine Capital's 13F filing for Q4 2021, filed 14 Feb 2022.